Secondary Amyloidosis
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT03346135) | City of Hope Medical Center | 2019-07-17 |
| Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma (NCT03311828) | City of Hope Medical Center | 2018-02-21 |
Track Secondary Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.